Decreased CD11b expression on circulating polymorphonuclear leukocytes in patients with extensive plaque psoriasis

European Journal of Dermatology

Volumn 7, Issue 5, 1997, Pages 324-328

  Van Pelt, Jan P A ^a   De Jong, Elke M G J ^a   Van Erp, Piet E J ^a   Van De Kerkhof, Peter C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood; CD11b; Flow cytometry; Leukotriene B4; Polymorphonuclear leukocyte; Psoriasis

Indexed keywords

CD11B ANTIGEN; INTEGRIN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; EXTRAVASATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MALE; PSORIASIS; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0030792237     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Christophers E, Mrowietz U. The Inflammatory Infiltrate in psoriasis. Clin Dermatol 1995; 13 (2): 131-5.
2. Prens E, Debets R, Hegmans J. T lymphocytes in p oriasis. Clin Dermatol 1995; 13 (2): 115-29.
3. Baker BS, Swain AF, Fry L, Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984; 110 (5): 555-64.
4. Placek W, Haftek M, Thivolet J. Sequence of changes in psoriatic epidermis. Immunocompetent cell redistribution precedes altered expression of keratinocyte differentiation markers. Acta Derm Venereol 1988; 68 (5): 369-77.
5. Chowaniec O, Jablonska S, Beutner EH, Proniewska M, Jarzabek Chorzelska M, Rzesa G. Earliest clinical and histological changes in psoriasis. Dermatologica 1981; 163 (1): 42-51.
6. Gordon M, Johnson WC. Histopathology and histochemistry of psoriasis. I. The active lesion and clinically normal skin. Arch Dermatol 1967; 95 (4): 402-7.
7. Van de Kerkhof PC, Chang A. Migration of polymorphonuclear leukocytes in psoriasis. Skin Pharmacol 1989; 2 (3): 138-54.
8. Glinski W, Barszcz D, Janczura E, Zarebska Z, Jablonska S. Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity. Br J Dermatol 1984; 111 (2): 147-54.
9. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346 (6283): 425-34.
10. Ruoslahti E. Integrins. J Clin Invest 1991; 87 (1): 1-5.
11. Tonnesen MG. Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium. J Invest Dermatol 1989; 93 (suppl. 2): 53S-8S.
12. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62 (1): 3-6.
13. Furie MB, Tancinco MC, Smith CW. Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 1991; 78 (8): 2089-97.
14. Lehr HA, Krombach F, Munzing S, Bodlaj R, Glaubitt SI, Seiffge D, et al. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 1995; 146 (1): 218-27.
15. De Haas M, Kerst JM, Van der Schoot CE, Calafat J, Hack CE, Nuijens JH, et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994; 84 (11): 3885-94.
16. Hasslen SR, Nelson RD, Ahrenholz DH, Solem LD. Thermal injury, the inflammatory process, and wound dressing reduce human neutrophil chemotaxis to four attractants. J Burn Care Rehabil 1993; 14 (3): 303-9.
17. Borregaard N, Kjeldsen L, Sengelov H, Diamond MS, Springer TA, Anderson HC, et al. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukoc Biol 1994; 56 (1): 80-7.
18. Brain S, Camp R, Dowd P, Black AK, Greaves M. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermotol 1984; 83 (1): 70-3.
19. Kragballe K, Voorhees JJ. Arachidonic acid ana leukotrienes in pathogenesis and treatment. In: Roenigk HH, Maibach HI, eds. Psoriasis. New York: Marcel Dekker, 1985; 255-63.
20. Voorhees JJ. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 1983; 119 (7): 541-7.
21. Greaves MW, Camp RD. Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin. Arch Dermatol Res 1988; 280 suppl.: S33-41.
22. Schroder JM. Inflammatory mediators and chemoattractants. Clin Dermatol 1995; 13 (2): 137-50.
23. Lundgren Akerlund E, Olofsson AM, Berger E, Arfors KE. CD11b/CD18-dependent polymorphonuclear leucocyte interaction with matrix proteins in adhesion and migration. Scand J Immunol 1993; 37 (5): 569-74.
24. Miller U, Bainton DF, Borregaard N, Springer TA. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 1987; 80 (2): 535-44.
25. Horrocks C, Duncan JI, Oliver AM, Thomson AW. Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A. Clin Exp Immunol 1991; 84 (1): 157-62.
26. Marder P, Schultz RM, Spaethe SM, Sofia MJ, Herron DK. Flow cytometric evaluation of the effects of leukotriene B4 receptor antagonists (LY255283 and SC-41930) on calcium mobilization and integrin expression of activated human neutrophils. Prostaglandins Leukot Essent Fatty Adds 1992; 46 (4): 265-70.
27. Van de Kerkhof PC, Lammers AM. Intraepidermal accumulation of polymorphonuclear leukocytes in chronic stable plaque psoriasis. Dermatologica 1987; 174 (5): 224-7.
28. Lammers AM, van de Kerkhof PC. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin. Br J Dermatol 1987; 116 (4): 521-4.
29. Wong E, Camp RD, Greaves MW. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4. J Invest Dermatol 1985; 84 (5): 421-3.
30. Krogballe K, Herlin T. Benoxaprofen improves psoriasis. A double-blind study. Arch Dermatol 1983; 119 (7): 548-52.
31. Black AK, Camp RD, Mallet AI, Cunningham FM, Hofbauer M, Greaves MW. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis. J Invest Dermatol 1990; 95 (1): 50-4.
32. De Jong EM, Van Vlijmen IM, Schölte JC, Buntinx A, Friedman B, Tanaka W, et al. Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis. Skin Pharmacol 1991; 4 (4): 278-85.
33. Van de Kerkhof PCM, van Pelt JPA, Lucker GPH, Steijlen PM, Heremans A. Topical R-85355 a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis. Skin Pharmacol 1997; 9: 307-12.